Oseltamivir(oral) · Infectious Disease Oseltamivir is a neuraminidase inhibitor that blocks the release of influenza virus particles from infected cells, reducing viral spread.
Phase 3 pipeline
Placebo to Oseltamivir · Infectious Disease / Virology This is a Phase 3 clinical trial comparing placebo to oseltamivir (Tamiflu), an antiviral neuraminidase inhibitor used to treat influenza.
Placebo to ZSP1273 · Diabetes ZSP1273 is a small molecule that acts as a selective and potent inhibitor of the sodium-glucose cotransporter 2 (SGLT2).
RAY1216 RAY1216 is an investigational therapeutic targeting a specific molecular pathway relevant to its indication, currently in phase 3 clinical development.
RAY1225 · Oncology RAY1225 is a selective inhibitor of fibroblast growth factor receptor (FGFR) signaling pathways.
Warfarin Sodium Tablets · Cardiovascular Warfarin inhibits vitamin K-dependent clotting factors (II, VII, IX, X) by blocking the vitamin K epoxide reductase enzyme, thereby reducing thrombin generation and preventing blood clot formation.
ZSP1273 · Infectious Diseases ZSP1273 is an influenza virus RNA-dependent RNA polymerase inhibitor that blocks viral replication.